|
Issue |
Title |
|
No 4-2 (2019) |
Dynamics of changes in water sectors in patients with alcoholic delirious syndrome |
Abstract
PDF (Rus)
|
A. G. Sofronov, V. N. Goncharov, V. Y. Skvortsov |
|
No 4-2 (2019) |
Current problems and development trends of specific complex methods for the diagnosis of neurotic disorders |
Abstract
PDF (Rus)
|
A. V. Ageykin, V. L. Melnikov, T. A. Karavaeva, A. V. Vasilieva, E. V. Kolesova, A. Yu. Tychkov, T. N. Dmitrieva, V. N. Gorbunov, E. A. Merkulova |
|
No 4-2 (2019) |
Self-regulation of behavior as one of the adaptation-compensatory mechanisms of the psyche in patients with paranoid schizophrenia. Article 2 |
Abstract
PDF (Rus)
|
V. Yu. Kudryashova, N. B. Lutova |
|
No 4-2 (2019) |
The dynamics of violations interoception in patients with anorexia nervosa during treatment |
Abstract
PDF (Rus)
|
A. A. Pichikov, Y. V. Popov, Y. A. Yakovleva, N. I. Ananieva, T. A. Salomatina, L. R. Akhmerova, E. V. Andreev |
|
No 4-2 (2019) |
The level of anxiety and depression in children and adolescents with chronic pain syndrome (on the example of juvenile idiopathic arthritis) |
Abstract
PDF (Rus)
|
A. V. Santimov, V. G. CHasnyk, S. V. Grechanyi |
|
No 4-2 (2019) |
Is sex a moderator of social functioning in patients with paranoid schizophrenia? |
Abstract
PDF (Rus)
|
A. G. Sofronov, V. E. Pashkovskiy, A. E. Dobrovolskaya, Ja. A. Getmanenko, A. N. Gvozdetsckii, S. A. Kolchev |
|
No 4-2 (2019) |
Evaluation of diagnostic parameters of scales of overcontrol and low control of the questionnaire of neurotic disorders |
Abstract
PDF (Rus)
|
L. I. Tsidik |
|
No 4-1 (2019) |
Word of welcome N.G. Neznanov |
Abstract
PDF (Rus)
|
N. G. Neznanov |
|
No 4-1 (2019) |
Genes of dopamine receptors and transporter in patients with schizophrenia: associations with the clinical characteristics of the disorder |
Abstract
PDF (Rus)
|
A. S. Boiko, I. V. Pozhidaev, O. Z. Paderina, A. V. Semke |
|
No 4-1 (2019) |
Association of polymorphic variants of serotonin receptor genes, serotonin synthesis and metabolism enzymes genes with depressive disorder and clinical remission |
Abstract
PDF (Rus)
|
N. M. Vyalova, G. G. Simutkin |
|
No 4-1 (2019) |
Type of course of schizophrenia and polymorphisms of neuronal protein kinase genes on the model of PIP5K2A, GSK3B and AKT1 |
Abstract
PDF (Rus)
|
E. G. Poltavskaya, O. Y. Fedorenko |
|
No 4-1 (2019) |
Candidate processes for autism spectrum disorders revealed by copy number variation analysis |
Abstract
PDF (Rus)
|
M. A. Zelenova, S. G. Vorsanova, I. Y. Iourov |
|
No 4-1 (2019) |
Epigenome editing of the potential enhancers of the schizophrenia risk genes: approaches for optimization of the genetic constructs |
Abstract
PDF (Rus)
|
D. A. Abashkin, A. O. Kurishev, S. V. Smirnova, D. S. Karpov, V. E. Golimbet |
|
No 4-1 (2019) |
The role of genetic research with family design in the study of affective disorders |
Abstract
PDF (Rus)
|
E. D. Kasyanov, G. E. Maso, A. O. Kibitov |
|
No 4-1 (2019) |
Effects of the COMT Val158Met polymorphism on N100 component of auditory evoked potential and oddball task performance in healthy subjects and schizophrenia patients |
Abstract
PDF (Rus)
|
A. A. Fedotova, A. V. Kirenskaya |
|
No 4-1 (2019) |
Genetic features of the dopaminergic neurotransmitter system in patients with alcohol dependence and depression comorbidity |
Abstract
PDF (Rus)
|
A. E. Nikolishin, V. M. Brodyansky, N. A. Chuprova, A. V. Solovieva, A. O Kibitov |
|
No 4-1 (2019) |
Polymorphic variants of xenobiotic metabolism genes and body mass index in schizophrenia patients receiving antipsychotic therapy |
Abstract
PDF (Rus)
|
I. V. Pozhidaev, A. S. Boiko, E. G. Kornetova |
|
No 4-1 (2019) |
Variability of response to pharmacotherapy of naltrexone and guanfacin in patients with opioid dependence syndrome: pharmacogenetic aspect |
Abstract
PDF (Rus)
|
V. Ya Palatkin, A. O. Kibitov, Е. M. Krupitsky, Е. A. Blokhina Е.A., V. M Brodyansky, Е. V. Verbitskaya, E. E. Zvartau |
|
No 4-1 (2019) |
The effectiveness of the preventive program aimed at the formation of sobriety in alcohol abusers does not depend on the level of genetic risk of substance abuse |
Abstract
PDF (Rus)
|
V. B. Vantej, A. N. Jakovlev, V. I. Vitchinkina |
|
No 4-1 (2019) |
Study of the polymorphic variants of the PIP5K2A gene association with the comorbidity of alcoholism and affective disorders |
Abstract
PDF (Rus)
|
E. V. Mikhalitskaya, O. V. Roshchina, S. A. Ivanova, N. A. Bokhan |
|
No 4-1 (2019) |
Machine learning methods for analyzing genomic and phenomic data in psychiatry |
Abstract
PDF (Rus)
|
T. I. Nurgaliev |
|
No 4-1 (2019) |
No association of rs1065852 and rs3892097 polymorphisms gene CYP2D6 with treatment resistant schizophrenia |
Abstract
PDF (Rus)
|
D. N. Sosin, M. V. Ivanov, L. M. Muslimova, D. V. Ivashchenko, D. A. Sychev |
|
No 4-1 (2019) |
Genomic mechanisms of anxiety and depression pathogenesis in experimental models |
Abstract
PDF (Rus)
|
A. V. Kalueff, K. A. Demin, A. D. Volgin |
|
No 4-1 (2019) |
Genetic risk factors of syndrome pain dysfunction of the temporomandibular joint |
Abstract
PDF (Rus)
|
J. V. Kotsiubinskaya |
|
No 4-1 (2019) |
The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations |
Abstract
PDF (Eng)
|
U. Heilbronner |
|
No 4-1 (2019) |
The prevalence of CYP2D6*10 (100C>T, rs1065852) gene polymorphism in Russian patients with epilepsy (North-Western and Siberian Districts) |
Abstract
PDF (Rus)
|
N. A. Sivakova, N. A. Shnayder, D. V. Dmitrenko, L. V. Lipatova, M. Y. Tolmachev, R. F. Nasyrova |
|
No 4-1 (2019) |
The PsyCourse Infrastructure as an Example for Longitudinal Research in Biological Psychiatry |
Abstract
PDF (Eng)
|
A. Gryaznova |
|
No 4-1 (2019) |
Multivariate polygenic models in personalized psychiatry |
Abstract
PDF (Rus)
|
М. V. Alfimova |
|
No 4-1 (2019) |
Genome-wide association studies in suicidology — analysis of main results |
Abstract
PDF (Rus)
|
V. A. Rozanov, G. E. Mazo, N. A. Kulemin, A. Yu. Gorbachev, E. D. Kasyanov |
|
No 4-1 (2019) |
Exploring genetic predictors of naltrexone treatment response in opioid use disorder |
Abstract
PDF (Rus)
|
Е. A. Blokhina ., E. М. Krupitsky, А. O. Kibitov, V. Ya. Palatkin, T. S. Yaroslavtseva, Е. V. Verbitskaya, E. E. Zvartau |
|
No 4-1 (2019) |
RDoC: integration or separation of neuroscience and psychopathology? |
Abstract
PDF (Rus)
|
R. V. Akhapkin |
|
No 4-1 (2019) |
Genetic markers of One-Carbon Metabolism Disorders in Schizophrenial |
Abstract
PDF (Rus)
|
T. V. Zhilyaeva, A. S. Piatoikina, A. S. Blagonravova, G. E. Mazo |
|
No 4-1 (2019) |
The opportunity of application of neurophysiological tests — schizophrenia endophenotypes for studying the role of genetic factors in cognitive processes in healthy subjects and in psychiatric diseases |
Abstract
PDF (Rus)
|
A. V. Kirenskaya, Z. I. Storozheva, F. O. Kibitov |
|
No 4-1 (2019) |
Genetic risks of addictive disorders in adolescents: phenotypic effects |
Abstract
PDF (Rus)
|
A. N. Yakovlev, N. V. Pashkevich, V. I. Vitchinkina |
|
No 4-1 (2019) |
Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode |
Abstract
PDF (Rus)
|
D. V. Ivashchenko, N. I. Buromskaya, P. V. Shimanov, D. V. Deitch., K. A. Ryzhykova, Е. A. Grishina, Yu. S. Shevchenko, D. A. Sychev |
|
No 4-1 (2019) |
Genetic and epigenetic aspects of depression and somatic disorders comorbidityon and somatic disorders comorbidity |
Abstract
PDF (Rus)
|
G. V. Rukavishnikov, G. E. Mazo, N. G. Neznanov, A. O. Kibitov |
|
No 4-1 (2019) |
Chromosomal abnormalities and copy number variations in children with idiopathic mental illness |
Abstract
PDF (Rus)
|
O. S. Kurinnaia, I. Y. Iourov, S. G. Vorsanova |
|
No 4-1 (2019) |
Polygenic risk score models based on anxiety-related traits as endophenotypes to predict unipolar depression and suicidal behavior |
Abstract
PDF (Rus)
|
A. V. Kazantseva, R. F. Enikeeva, Yu. D. Davydova, R. G. Valinurov, I. Yu. Ahmerova I.Yu., S. B. Malykh, M. M. Lobaskova, E. K. Khusnutdinova |
|
No 4-1 (2019) |
Dopamine transporter knockout rats as the new preclinical model of hyper- and hypo-dopaminergic disorders |
Abstract
PDF (Rus)
|
I. Sukhanov, D. Leo, M. A. Tur, I. V. Belozertseva, A. Savchenko, R. R. Gainetdinov |
|
No 4-1 (2019) |
Therapeutic resistance in depression from the genetics and pharmacogenetics point of view |
Abstract
PDF (Rus)
|
G. E. Mazo, G. V. Rukavishnikov, A. O. Kibitov |
|
No 4-1 (2019) |
Genetic aspects of non-motor symptoms in Parkinson’s disease |
Abstract
PDF (Rus)
|
N. Y. Safonova |
|
No 4-1 (2019) |
Post-GWAS era in genetics of schizophrenia |
Abstract
PDF (Rus)
|
V. E. Golimbet, A. K. Golov, N. V. Kondratyev |
|
No 4-1 (2019) |
Using polygenic risk score approaches to investigate the common-variant genetic architecture of schizophrenia |
Abstract
PDF (Eng)
|
V. Escott-Price |
|
No 4-1 (2019) |
Pharmacogenetics of chemical addictions |
Abstract
PDF (Rus)
|
E. M. Krupitsky, E. A. Akhmetova, A. R. Asadullin |
|
No 4-1 (2019) |
New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia |
Abstract
PDF (Rus)
|
S. A. Ivanova |
|
No 4-1 (2019) |
Clinical and pharmacological technologies of personalized medicine: what now and what will happen? |
Abstract
PDF (Rus)
|
D. A. Sychev |
|
No 4-1 (2019) |
Genetic Predictors of Lithium Response |
Abstract
PDF (Eng)
|
U. Heilbronner |
|
No 4-1 (2019) |
Does psychiatric molecular genetics need to account for the birth cohort effect? |
Abstract
PDF (Eng)
|
J. Harro, K. Laas, M. Vaht, D. Eensoo, T. Kurrikoff, K. Sakala, E. Kiive, T. Veidebaum |
|
No 4-1 (2019) |
Russian National Consortium for Psychiatric Genetics: results of the first two years of work, development opportunities and international collaborations |
Abstract
PDF (Rus)
|
A. O. Kibitov |
|
No 4-1 (2019) |
Dopamine Genetics: Substance Use Disorders vs. Parkinson’s Disease |
Abstract
PDF (Eng)
|
Z. Carl Lin, F. S. Hall, R. L. Bell |
|
1 - 50 of 146 Items |
1 2 3 > >>
|